AFRAMP enables rapid US-based production of PPE, medical supplies
An 11th Security Support Squadron member wears a mask received through a pilot initiative called the Air Force Rapid Agile Manufacturing Platform at Joint Base Andrews, Md., May 15, 2020. The framework is designed to keep the Air Force supply system independent of the civilian medical market.
U.S. Air Force courtesy photo

AFRAMP enables rapid US-based production of PPE, medical supplies

The Air Force is piloting an initiative called the Rapid Agile Manufacturing Platform to leverage the full capacity of the U.S. manufacturing base.

Subscribe

To respond to the growing demand for COVID-19-related supplies, the Air Force is piloting an initiative called the Rapid Agile Manufacturing Platform to leverage the full capacity of the U.S. manufacturing base. 

This initiative, which kicked off on April 10 as part of the Department of the Air Force Acquisition COVID-19 Task Force, is designed as a framework to keep the Air Force supply system independent of the civilian medical supply market. 

“This pandemic has placed a massive strain on the medical industry due to a significant increase in demand for supplies like masks and ventilators,” said Maj. Chris Wood, DAF ACT AFRAMP lead. “Many U.S.-based suppliers are doing what they can to increase their capacity, but there’s more unmet demand out there. We decided to turn to nontraditional suppliers — like car manufacturers and 3D-printing factories — to explore how they can contribute in making different products for the Department of the Air Force.”

Read the full article By Staff Sgt. Jordyn Fetter, AFWERX Public Affairs, here.